HK1152652A1 - Pharmaceutical solid preparation having active ingredients separated by boundary therein - Google Patents
Pharmaceutical solid preparation having active ingredients separated by boundary thereinInfo
- Publication number
- HK1152652A1 HK1152652A1 HK11106770.0A HK11106770A HK1152652A1 HK 1152652 A1 HK1152652 A1 HK 1152652A1 HK 11106770 A HK11106770 A HK 11106770A HK 1152652 A1 HK1152652 A1 HK 1152652A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- boundary
- active ingredients
- solid preparation
- pharmaceutical solid
- ingredients separated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008227971 | 2008-09-05 | ||
PCT/JP2009/065390 WO2010027010A1 (ja) | 2008-09-05 | 2009-09-03 | 有効成分が境界を有してなる医薬固形製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1152652A1 true HK1152652A1 (en) | 2012-03-09 |
Family
ID=41797176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11106770.0A HK1152652A1 (en) | 2008-09-05 | 2011-07-04 | Pharmaceutical solid preparation having active ingredients separated by boundary therein |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2335698B8 (xx) |
JP (1) | JP5579066B2 (xx) |
KR (1) | KR101640958B1 (xx) |
CN (1) | CN102137664B (xx) |
BR (1) | BRPI0919194A2 (xx) |
HK (1) | HK1152652A1 (xx) |
MX (1) | MX2011002400A (xx) |
TW (1) | TWI436763B (xx) |
WO (1) | WO2010027010A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0918539A2 (pt) * | 2008-09-12 | 2015-12-08 | Daiichi Sankyo Healthcare Co | preparação farmacêutica sólida para administração oral |
EP2695605B1 (en) | 2012-08-07 | 2017-05-03 | Parapharm Development Ltd. | Tranexamic acid composition |
CN103054861A (zh) * | 2012-12-29 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种含氨甲环酸的复方固体制剂 |
CN109793757B (zh) * | 2019-03-28 | 2021-06-22 | 北京刷新活力健康科技有限公司 | 一种抑制皮肤瘢痕生长的组合物及其制备方法和应用 |
JP2021001126A (ja) * | 2019-06-20 | 2021-01-07 | 小林製薬株式会社 | ケラチノサイト内メラノソーム分解促進剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01102073A (ja) * | 1987-10-15 | 1989-04-19 | Takeda Chem Ind Ltd | 安定なアスコルビン酸粉末およびその製造法 |
JPH04243825A (ja) | 1991-01-25 | 1992-08-31 | Ss Pharmaceut Co Ltd | 色素沈着症治療剤 |
TW271406B (xx) * | 1992-04-17 | 1996-03-01 | Takeda Pharm Industry Co Ltd | |
JP2001294524A (ja) * | 2000-04-12 | 2001-10-23 | Taisho Pharmaceut Co Ltd | アセトアミノフェン配合内服固形製剤 |
JP4786127B2 (ja) * | 2002-07-12 | 2011-10-05 | 任康 高田 | 色素沈着改善治療薬 |
JP2004217655A (ja) * | 2002-12-27 | 2004-08-05 | Dai Ichi Seiyaku Co Ltd | 美白用組成物 |
KR20080022592A (ko) * | 2002-12-27 | 2008-03-11 | 다이이찌 세이야꾸 가부시기가이샤 | 미백용 조성물 |
US8277844B2 (en) * | 2003-08-20 | 2012-10-02 | Shionogi & Co., Ltd. | Coating composition |
JP2005314403A (ja) * | 2004-03-31 | 2005-11-10 | Dai Ichi Seiyaku Co Ltd | 新規美白用組成物 |
WO2006003965A1 (ja) * | 2004-06-30 | 2006-01-12 | Daiichi Sankyo Healthcare Co., Ltd. | 美白組成物 |
JP4768404B2 (ja) * | 2005-11-08 | 2011-09-07 | 株式会社 資生堂 | イオントフォレーシスによる美容方法 |
JP2008201711A (ja) * | 2007-02-20 | 2008-09-04 | Ss Pharmaceut Co Ltd | システイン臭が低減された固形製剤 |
-
2009
- 2009-09-03 JP JP2010527810A patent/JP5579066B2/ja active Active
- 2009-09-03 WO PCT/JP2009/065390 patent/WO2010027010A1/ja active Application Filing
- 2009-09-03 EP EP09811535.5A patent/EP2335698B8/en active Active
- 2009-09-03 MX MX2011002400A patent/MX2011002400A/es not_active Application Discontinuation
- 2009-09-03 KR KR1020117005172A patent/KR101640958B1/ko active IP Right Grant
- 2009-09-03 BR BRPI0919194A patent/BRPI0919194A2/pt not_active IP Right Cessation
- 2009-09-03 CN CN200980134233.8A patent/CN102137664B/zh active Active
- 2009-09-04 TW TW098129783A patent/TWI436763B/zh active
-
2011
- 2011-07-04 HK HK11106770.0A patent/HK1152652A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN102137664A (zh) | 2011-07-27 |
JP5579066B2 (ja) | 2014-08-27 |
TW201016213A (en) | 2010-05-01 |
EP2335698B8 (en) | 2014-06-25 |
BRPI0919194A2 (pt) | 2015-12-15 |
JPWO2010027010A1 (ja) | 2012-02-02 |
EP2335698A4 (en) | 2011-10-12 |
WO2010027010A1 (ja) | 2010-03-11 |
KR20110057145A (ko) | 2011-05-31 |
CN102137664B (zh) | 2014-08-06 |
MX2011002400A (es) | 2011-04-07 |
EP2335698A1 (en) | 2011-06-22 |
TWI436763B (zh) | 2014-05-11 |
KR101640958B1 (ko) | 2016-07-19 |
EP2335698B1 (en) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2130552A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE | |
ZA201005015B (en) | Solid pharmaceutical dosage form | |
ZA201006029B (en) | Pharmaceutical dosage form | |
IL208370A0 (en) | Improved formulations for poorly permeable active pharmaceutical ingredients | |
EP2561892A4 (en) | SOLID PREPARATION EASILY ADMINISTRABLE | |
EP2447253A4 (en) | DIHYDROPYRIMIDIN COMPOUNDS AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
ZA201104348B (en) | Pharmaceutical preparation | |
EP2468771A4 (en) | PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE | |
WO2009135593A3 (de) | Feste arzneimittelformulierung mit verzögerter freisetzung | |
IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
EP2241569A4 (en) | THIENOPYRIDAZINE COMPOUNDS, PREPARATIONS THEREOF, PHARMACEUTICAL COMPOSITIONS AND USES | |
ZA200903858B (en) | Pharmaceutical dosage form | |
ZA201102715B (en) | Solid pharmaceutical composition | |
GB0815972D0 (en) | Pharmaceutical preparation | |
EP2504331A4 (en) | COMPOUND, SOME NEW FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF PREPARATION AND USE | |
IL219617A0 (en) | Pharmaceutical solid dosage form | |
EP2306998A4 (en) | PHARMACEUTICAL FORMULATION | |
EP2002828A4 (en) | SOLID PHARMACEUTICAL PREPARATION | |
IL213671A0 (en) | Pharmaceutical composition comprising aleglitazar | |
HK1152652A1 (en) | Pharmaceutical solid preparation having active ingredients separated by boundary therein | |
IL208788A (en) | Pharmacy-based formulation | |
ZA201100871B (en) | Solid pharmaceutical composition | |
IL212171A (en) | 1-Phenylpyrol compounds, pharmaceuticals containing them and their use | |
IL206739A (en) | An injectable drug containing silitol as an active substance | |
IL213200A0 (en) | Acetals as parfuming ingredients |